No Data
No Data
Rating information (Target Price change - Part 2) = Mitsukoshi Isetan, Japan New Drug ETC.
◎Mizuho Securities (three-stage: Buy > Hold > underperform) Mitsukoshi Isetan <3099.T> - "Hold" → "Hold", 2400 yen → 2600 yen Sotetsu Holdings <9003.T> - "Hold" → "Hold", 2900 yen → 2700 yen Mitsui Trust Holdings <9302.T> - "Hold" → "Hold", 4800 yen → 8000 yen ◎Morgan Stanley MUFG Securities (three-stage: Overweight > Equal Weight > Underweight) Nippon Shinyaku <4516.T> - "Eico"
Key points of attention for PTS on the 5th = SBI Leos, Daiichi Construction, WOLVES.
▽ SBI Reos <165A.T>, the introduction of a shareholder incentive program after the Earnings Reports. ▽ Daiichi Construction <1799.T>, Earnings Reports and revision of Financial Estimates. ▽ WOLVES <194A.T>, acquisition of stocks of Bahati (becoming a subsidiary). ▽ CubeSys <2335.T>, Earnings Reports and revision of Financial Estimates. ▽ Sato Foods <2923.T>, decision to grant large-scale growth investment subsidies for wage increases aimed at small and medium-sized enterprises. ▽ Mie Transportation HD <3232.T>, Earnings Reports and expansion of the shareholder incentive program. ▽ AEA.
Seria Logs 18% Higher Profit for Nine Months to December 2024
Seria Co. Reports Strong Quarterly Growth
Seria: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
Seria Co Ltd 9-Mos Parent Net Y8.87B Vs Net Y7.49B